
VRSK: Analytics Growth vs Rich Valuation
Verisk ($VRSK) is benefiting from AI-driven demand and a large addressable insurance analytics market, yet it trades at a premium and has shown recent volatility. This report breaks down drivers, risks, valuation and near-term catalysts heading into Q1 2026 results.
Executive Summary
Investment Thesis: Verisk ($VRSK) is a leader in insurance-focused data analytics and risk solutions, with strong recurring revenue, healthy margins and AI-driven product momentum. Analysts remain broadly constructive, and the expanding insurance analytics market provides a multi-year growth runway. However, the stock trades at elevated multiples versus historical averages and peers, and insurance cycle volatility plus recent share-price drawdowns introduce execution and timing risk.
Current Price: $201.77 as of Friday, March 20 | Key Metric: Market Cap $27.76B | Stance: NEUTRAL
Company Overview
Verisk Analytics, Inc. ($VRSK) provides data analytics, predictive modeling and software solutions primarily to the global insurance industry, plus clients in financial services, government and energy. The company combines proprietary datasets, actuarial models and software to support underwriting, claims, catastrophe modeling and fraud detection.
Key Products & Competitive Position
- Core Business: Recurring analytics and software subscriptions for insurance underwriting, claims and risk management, supported by actuarial models and catastrophe analytics.
- Key Products: Underwriting/rating platforms, catastrophe models, claims analytics, fraud detection tools and life insurance solutions.
- Competitive Moat: Large proprietary datasets, domain expertise in insurance actuarial science, deep customer relationships and high switching costs for core workflow integrations.
Recent Developments
Public commentary and research over the past two weeks highlights Verisk's AI work on fraud detection, and third party research projects the insurance analytics market expanding materially through 2033. Several analysts have revised targets recently, with upgrades such as Raymond James in early March. At the same time the stock experienced significant volatility since mid-2025, creating a wider trading range and raising debate about valuation versus growth durability.
Financial Snapshot
Revenue & Earnings Trends
Verisk benefits from a high mix of recurring revenue from subscriptions and services, which helps generate consistent free cash flow. Publicly reported quarterly revenue and operating performance have shown steady top-line growth, though the company can see quarter-to-quarter variability tied to timing of large projects, acquisitions and insurance industry cycle items. Trailing twelve month EPS is $6.48, and profit margins remain elevated versus typical professional services peers due to software-like economics and data licensing leverage.
Balance Sheet Highlights
Verisk's balance sheet is conservative on liquidity with a current ratio around 1.20, indicating adequate short-term coverage. The company carries debt related to past acquisitions but generates strong operating cash flow that supports buybacks and modest dividends. Note that a high ROE figure is amplified by share repurchases and relatively low reported book equity, so ROE should be interpreted with care.
Valuation Analysis
Current Valuation Metrics
Historical Comparison
On a trailing P/E and P/S basis $VRSK trades above its multi-year averages and typically commands a premium to broader professional services and insurance tech peers. The premium reflects data exclusivity and sticky revenue, but the stock's valuation expanded notably during the 2024-25 rally and has been partially reset after the 2026 pullback from the $322 high.
Fair Value Estimate
Using a hybrid approach that blends a forward multiple (around 20-25x forward EPS) with conservative growth assumptions and a sensitivity to margin expansion, a central fair value falls in the low-mid $200s. That aligns with consensus analyst means near $245, implying roughly 20% upside from current levels. At the same time downside to the high-teens to low-$100s remains plausible if growth disappoints or insurance spending retracts.
Competitive Landscape
Market Position
Market Share: Significant in specialized insurance analytics niches | Ranking: Top-tier provider in insurance risk and analytics
Key Competitors
Competitive Advantages
- Moat 1: Proprietary, high-quality insurance datasets and decades of actuarial modeling.
- Moat 2: Deep integration into insurer workflows that creates high switching costs.
- Moat 3: Strong brand and regulatory credibility for catastrophe and risk modeling.
Earnings Track Record
Last 4 Quarters: 3 beats / 1 miss
Recent Earnings History
Guidance Trend
Management tends to guide conservatively and emphasize long-term contract metrics such as ARR like figures and renewal rates. Analysts note that guidance has been modestly upgraded by some brokers based on product traction, but the picture can shift around insurance cycle commentary or large contract timing.
Analyst Sentiment
Consensus Rating:
Price Targets
- Low: $195
- Mean: $245.81 (+21.8% upside)
- High: $300
Recent Analyst Actions
Raymond James upgraded $VRSK to Strong Buy in early March with an increased target, citing product momentum and attractive entry following the pullback. Wells Fargo and other analysts have maintained constructive ratings while adjusting targets to reflect recent volatility. The consensus remains on the buy side, but coverage is mixed with a meaningful number of Hold ratings, reflecting valuation sensitivity.
Recent News & Catalysts
Key Developments
- Stock Reaction Since Earnings: Traders noted a roughly 9.7% gain since the most recent earnings report, with analysts parsing guidance and license metrics for further upside, according to media coverage on 3/20/2026.
- Institutional Commentary: A Q4 investor letter from TimesSquare Capital noted a retreat in shares, highlighting recent volatility and portfolio positioning conversations, per reporting on 3/20/2026.
- Market Opportunity: Research published 3/20/2026 forecasts the insurance analytics market could expand materially through 2033, which supports a long-term TAM narrative that includes providers such as Verisk.
- Product Research: Verisk released research on AI-assisted fraud risk showing rising digital alteration of claims, underscoring demand for advanced fraud detection tools, reported 3/17/2026.
Upcoming Catalysts
Next Earnings: Expected 2026-05-05 Before Market | Key Events: ARR or subscription metrics, margin guidance, commentary on AI product deployments and any large contract timing.
Technical Outlook
Current Price: $201.77 as of Friday, March 20 vs 52-Week High: $322.92 (-37.5% from high)
Trend Analysis
Price action since mid-2025 shows a sharp run higher then a significant retracement into early 2026. Momentum indicators are mixed, with the stock finding support near the mid $160s earlier this year and consolidating in the $180 to $220 range more recently. Volume patterns suggest that moves are often sentiment driven around earnings and analyst notes.
Key Levels
- Resistance: $230, $265
- Support: $165, $190
Bull vs Bear Case
Bull Case
- Catalyst 1: Accelerating adoption of AI and advanced analytics by insurers drives ARR expansion and upsell.
- Catalyst 2: Large addressable market growth to 2033 provides multi-year revenue runway and justifies premium multiples.
- Catalyst 3: Operational leverage and margin expansion from software-like revenue mix lead to higher free cash flow and investor re-rating.
Bull Target: $300 (+48.6%)
Bear Case
- Risk 1: Continued multiple compression if growth slows or insurance spend softens in a cyclical slowdown.
- Risk 2: Competitive pressure or a failure to convert AI research into paid product adoption could slow ARR growth.
- Risk 3: Valuation vulnerability given premium metrics; any revenue miss could cause outsized downside.
Bear Target: $150 (-25.6%)
Risks to Consider
- Valuation Risk: $VRSK trades at a premium on P/S and forward multiples. The stock is sensitive to growth disappointments or downgrades.
- Competitive Risk: Large tech platforms and niche analytics firms are accelerating AI and cloud offerings, which could erode pricing power over time.
- Macro Risk: Insurance underwriting spend can be cyclical and tied to broader economic conditions and reinsurance pricing.
- Execution Risk: Converting AI research and new product initiatives into recurring revenue at scale is not guaranteed and depends on sales cycles with large insurers.
Bottom Line
Investment Verdict: NEUTRAL
Verisk occupies a leading position in a potentially large and growing insurance analytics market, and recent analyst upgrades reflect confidence in product momentum. At the same time valuation is elevated and the stock has shown material volatility, so the risk-reward at current levels is balanced rather than skewed decisively one way.
Action Items for Investors
- Long-term investors: Monitor updates on ARR-like metrics, renewal rates and progress commercializing AI products, and consider building positions over time on weakness rather than entering fully at current valuations.
- Short-term traders: Watch earnings on 2026-05-05 and analyst reactions, trade around key technical levels and use defined stops due to volatility.
- Risk management: Use position sizing and consider hedging around earnings if your exposure is significant, given sensitivity to guidance and multiple re-ratings.
What to Watch This Week
- Analyst notes and conference commentary following recent news coverage, investors parse the 3/20 articles for signals on positioning.
- Any incremental product announcements or case studies on AI-driven fraud detection adoption.
- Macro headlines that could affect insurance underwriting spending and reinsurance rates.
Sources
Share this report
Share this article
Spread the word on social media
Think VRSK will outperform? Prove it.
Free practice contests — earn Alpha CoinsExplore More Content
Disclaimer: StockAlpha.ai content is for informational and educational purposes only. It is not personalized investment advice. Sentiment ratings and market analysis reflect data-driven observations, not buy, sell, or hold recommendations. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.